eIF5A, 1-154aa, Human, E Coli from MYBIOSOURCE INC.
Search, find, compare suppliers for eIF5A, 1-154aa, Human, E Coli products.
| Edit | |
|---|---|
| Product Name | eIF5A, 1-154aa, Human, E Coli |
| Description | Purity > 95% by SDS-PAGE. Eukaryotic translation initiation factor 5A (eIF5A) is the only protein Known to contain unusual amino acid formed by the action of deoxyhypusine synthase and deoxyhypusine hydroxylase using spermidine as the substrate. This protein was previously reported to be involved in the first step of peptide bond formation in translation; however more recent work implicates it as a universally conserved translation elongation factor. Modulation of eIF5A has been linked to proliferation and cancer. Recombinant human eIF5A protein was expressed in E. coli and purified by using conventional chromatography techniques. MW: 16.8 kDa (154 aa), confirmed by MALDI-TOF. |
| Size | 0.1 mg, 0.5 mg |
| Concentration | 1.0 mg/ml (determined by Bradford assay) |
| Applications | SDS-PAGE |
| Other Names | [Eukaryotic translation initiation factor 5A isoform B; EIF-5A; EIF5A1; eIF5AI; Eukaryotic translation initiation factor 5A isoform B eIF 4D; EIF 5A; eIF 5A 1; eIF 5A1; eIF4D; uORF; uORF A; Eukaryotic initiation factor 5A; Rev binding factor; Eukaryotic initiation factor 5A isoform 1; MGC99547; Eukaryotic translation initiation factor 5A; Eukaryotic translation initiation factor 5A 1; MGC104255.], [EIF5A; eIF-5A-1; eIF-5A1; eIF-5A] |
| Gene, Accession, CAS # | [eIF5A], Gene ID: 1984, NCBI: NP_001961, UniProt: P63241 |
| Catalog # | MBS203210 |
| Price | $310, $720 |
| Order / More Info | eIF5A, 1-154aa, Human, E Coli from MYBIOSOURCE INC. |
| Product Specific References | Saini P, et al. (2009). Nature. 459 (7243):118-21; Gosslau A., et al. (2009). J Cell Physiol. 219 (2):485-93; |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.